Reuters logo
BRIEF-ArQule shares tumble following news experimental cancer drug fails
January 11, 2013 / 1:05 PM / 5 years ago

BRIEF-ArQule shares tumble following news experimental cancer drug fails

NEW YORK, Jan 11 (Reuters) - ArQule Inc : * Shares down 20 percent in premarket trade on news experimental cancer drug

fails mid-stage study

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below